NCT01072825 A European Network for the Investigation of Gender Incongruence
| NCT ID | NCT01072825 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Ghent |
| Condition | Physical and Psychological Evaluation of Hormonal Therapy in Transsexual Persons |
| Study Type | OBSERVATIONAL |
| Enrollment | 125 participants |
| Start Date | 2010-02-15 |
| Primary Completion | 2030-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 125 participants in total. It began in 2010-02-15 with a primary completion date of 2030-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The physical and psychological effects of the hormonal treatment of transsexual persons are not sufficiently described. 'Transparency' wants to answer this question in a prospective manner, in a multicenter study to describe these effects. The low prevalence of transsexualism was the stimulus to search for European partners for this Protocol. A common standardized hormonal protocol was designed.
Eligibility Criteria
Inclusion Criteria: * Transsexual persons older then 18 years, who are not yet treated with hormonal therapy. Exclusion Criteria: \-
Contact & Investigator
Guy T'Sjoen, MD
✉ guy.tsjoen@ugent.beGuy T'Sjoen, MD
PRINCIPAL INVESTIGATOR
University Hospital, Ghent
Frequently Asked Questions
Who can join the NCT01072825 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Physical and Psychological Evaluation of Hormonal Therapy in Transsexual Persons. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT01072825 currently recruiting?
Yes, NCT01072825 is actively recruiting participants. Contact the research team at guy.tsjoen@ugent.be for enrollment information.
Where is the NCT01072825 trial being conducted?
This trial is being conducted at Ghent, Belgium, Florence, Italy, Amsterdam, Netherlands, Oslo, Norway.
Who is sponsoring the NCT01072825 clinical trial?
NCT01072825 is sponsored by University Hospital, Ghent. The principal investigator is Guy T'Sjoen, MD at University Hospital, Ghent. The trial plans to enroll 125 participants.